Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Head and Neck Cancer

  Free Subscription


26.08.2019

1 Am J Pathol
1 Ann Otol Rhinol Laryngol
2 Ann Thorac Surg
2 BMC Cancer
2 Br J Oral Maxillofac Surg
2 Clin Cancer Res
1 Clin Nucl Med
1 Gastrointest Endosc
5 Head Neck
1 Histopathology
2 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Laryngol Otol
11 Laryngoscope
16 Oral Oncol
5 Radiother Oncol
1 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Pathol

  1. LIU R, Li X, Hylemon PB, Zhou H, et al
    Conjugated bile acids promote invasive growth of esophageal adenocarcinoma cells and cancer stem cell expansion via sphingosine 1-phosphate receptor 2 (S1PR2)-mediated YAP activation.
    Am J Pathol. 2018 Jun 29. pii: S0002-9440(18)30130.
    PubMed     Text format     Abstract available


    Ann Otol Rhinol Laryngol

  2. SOLDATOVA L, Mirza N
    Long-Term Voice and Swallowing Outcomes for Oral and Oropharyngeal Cancer Following Primary or Adjuvant Chemoradiation.
    Ann Otol Rhinol Laryngol. 2019;128:802-810.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  3. CHANG AC
    Centralizing Esophagectomy to Improve Outcomes and Enhance Clinical Research: Invited Expert Review.
    Ann Thorac Surg. 2018 May 5. pii: S0003-4975(18)30591.
    PubMed     Text format     Abstract available

  4. MASABNI K, Kandagatla P, Popoff AM, Rubinfeld I, et al
    Is Esophagectomy for Benign Conditions Benign?
    Ann Thorac Surg. 2018 Apr 21. pii: S0003-4975(18)30542.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. NIU X, Fang Q, Liu F
    Role of intraparotid node metastasis in mucoepidermoid carcinoma of the parotid gland.
    BMC Cancer. 2019;19:417.
    PubMed     Text format     Abstract available

  6. KOIZUMI W, Kitago M, Shinoda M, Yagi H, et al
    Successful resection of pancreatic metastasis from oesophageal squamous cell carcinoma: a case report and review of the literature.
    BMC Cancer. 2019;19:320.
    PubMed     Text format     Abstract available


    Br J Oral Maxillofac Surg

  7. BAHEERATHAN NN, Ilankovan V
    Re: Squamous cell carcinoma of the tongue in a patient with dyskeratosis congenita: a rare entity.
    Br J Oral Maxillofac Surg. 2019;57:389.
    PubMed     Text format    

  8. FATEHI KS, Thiagarajan S
    Re: re: Squamous cell carcinoma of the tongue in a patient with dyskeratosis congenita: a rare entity.
    Br J Oral Maxillofac Surg. 2019;57:390.
    PubMed     Text format    


    Clin Cancer Res

  9. MELL LK, Shen H, Nguyen-Tan PF, Rosenthal DI, et al
    Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer.
    Clin Cancer Res. 2019 Aug 16. pii: 1078-0432.CCR-19-1832.
    PubMed     Text format     Abstract available

  10. DE ROEST RH, Mes S, Brink A, Poell JB, et al
    Molecular characterization of locally relapsed head and neck cancer after concomitant chemoradiotherapy.
    Clin Cancer Res. 2019 Aug 22. pii: 1078-0432.CCR-19-0628.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  11. YANG J, Li Y, Li J, Yang P, et al
    Hyperparathyroidism Due to Concurrent Parathyroid Carcinoma and Parathyroid Adenoma.
    Clin Nucl Med. 2019 Aug 20. doi: 10.1097/RLU.0000000000002755.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  12. WANG G, Liu BR, Hu Z
    Combined Endoscopic-Laparoscopic Radical Esophagectomy and Lymph Node Dissection for the Treatment of Esophageal Squamous Cell Carcinoma.
    Gastrointest Endosc. 2019 Aug 20. pii: S0016-5107(19)32142.
    PubMed     Text format    


    Head Neck

  13. TAN AL, Iyer NG, Putri N, Nadkarni N, et al
    Factors driving frequent attendance at emergency departments for patients with head and neck cancer.
    Head Neck. 2019 Aug 18. doi: 10.1002/hed.25916.
    PubMed     Text format     Abstract available

  14. CHO Y, Yoon HI, Lee IJ, Kim JW, et al
    Patterns of local recurrence after curative resection and reconstruction for oropharyngeal and oral cancers: Implications for postoperative radiotherapy target volumes.
    Head Neck. 2019 Aug 20. doi: 10.1002/hed.25928.
    PubMed     Text format     Abstract available

  15. MIMICA X, Hanson M, Patel SG, McGill M, et al
    Salvage surgery for recurrent larynx cancer.
    Head Neck. 2019 Aug 21. doi: 10.1002/hed.25925.
    PubMed     Text format     Abstract available

  16. ELDRIDGE RC, Pugh SL, Trotti A, Hu K, et al
    Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study.
    Head Neck. 2019 Aug 22. doi: 10.1002/hed.25922.
    PubMed     Text format     Abstract available

  17. CHEN JH, Huang WY, Ho CL, Chao TY, et al
    Evaluation of oral tegafur-uracil as metronomic therapy following concurrent chemoradiotherapy in patients with non-distant metastatic TNM stage IV nasopharyngeal carcinoma.
    Head Neck. 2019 Aug 22. doi: 10.1002/hed.25904.
    PubMed     Text format     Abstract available


    Histopathology

  18. KAYE P, Lindsay D, Madhusudan S, Vohra R, et al
    Upper GI biopsies for adenocarcinoma - how many biopsies should endoscopists take?
    Histopathology. 2019;74:959-963.
    PubMed     Text format     Abstract available


    Int J Cancer

  19. JARGIN SV
    Thyroid neoplasia after Chernobyl: A comment.
    Int J Cancer. 2019;144:2897.
    PubMed     Text format    

  20. TRONKO M, Brenner AV, Bogdanova T, Shpak V, et al
    Reply to letter: Thyroid neoplasia after Chernobyl: A comment.
    Int J Cancer. 2019;144:2898.
    PubMed     Text format    


    Int J Radiat Oncol Biol Phys

  21. YOUNG MR, Decker RH
    SBRT for Early Stage Laryngeal Cancer: Progress, But Not Quite Ready for Prime Time.
    Int J Radiat Oncol Biol Phys. 2019;105:121-123.
    PubMed     Text format    


    J Laryngol Otol

  22. GOUZOS M, Dale O, Sethi N, Foreman A, et al
    Elective neck dissection for the node-negative neck during salvage laryngectomy: an analysis of survival outcomes and complication rates.
    J Laryngol Otol. 2019 Aug 22:1-4. doi: 10.1017/S0022215119001725.
    PubMed     Text format     Abstract available


    Laryngoscope

  23. BERGER MH, Tajudeen BA, St John MA, Tjoa T, et al
    Should an elective neck dissection be performed for maxillary sinus squamous cell carcinoma?
    Laryngoscope. 2019 Aug 16. doi: 10.1002/lary.28242.
    PubMed     Text format    

  24. GOLDSTEIN DP, Sklar MC, de Almeida JR, Gilbert R, et al
    Frailty as a predictor of outcomes in patients undergoing head and neck cancer surgery.
    Laryngoscope. 2019 Aug 16. doi: 10.1002/lary.28222.
    PubMed     Text format     Abstract available

  25. LEHMAN CE, Khalil AA, Axelrod MJ, Dougherty MI, et al
    Antitumor effect of insulin-like growth factor-1 receptor inhibition in head and neck squamous cell carcinoma.
    Laryngoscope. 2019 Aug 21. doi: 10.1002/lary.28236.
    PubMed     Text format     Abstract available

  26. LIN KT, Lee SY, Liu SC, Tsao CC, et al
    Risk of ocular complications following radiation therapy in patients with nasopharyngeal carcinoma.
    Laryngoscope. 2019 Aug 23. doi: 10.1002/lary.28254.
    PubMed     Text format     Abstract available

  27. TIRELLI G, Boscolo Nata F, Gatto A, Bussani R, et al
    Intraoperative Margin Control in Transoral Approach for Oral and Oropharyngeal Cancer.
    Laryngoscope. 2019;129:1810-1815.
    PubMed     Text format     Abstract available

  28. CHANG S, Sanii R, Chaudhary H, Lewis C, et al
    Evaluation of early oral cavity cancer treatment quality at a single institution.
    Laryngoscope. 2019;129:1816-1821.
    PubMed     Text format     Abstract available

  29. PATEL TD, Echanique KA, Yip C, Hsueh WD, et al
    Supraglottic Squamous Cell Carcinoma: A Population-Based Study of 22,675 Cases.
    Laryngoscope. 2019;129:1822-1827.
    PubMed     Text format     Abstract available

  30. CAMILON PR, Rahbar R, Cunningham MJ, Adil EA, et al
    Juvenile nasopharyngeal angiofibroma in prepubertal males: A diagnostic dilemma.
    Laryngoscope. 2019;129:1777-1783.
    PubMed     Text format     Abstract available

  31. MASSEY C, Dharmarajan A, Bannuru RR, Rebeiz E, et al
    Management of N0 neck in early oral squamous cell carcinoma: A systematic review and meta-analysis.
    Laryngoscope. 2019;129:E284-E298.
    PubMed     Text format     Abstract available

  32. MIZUNO K, Takeuchi M, Kanazawa Y, Kitamura M, et al
    Recurrent laryngeal nerve paralysis after thyroid cancer surgery and intraoperative nerve monitoring.
    Laryngoscope. 2019;129:1954-1960.
    PubMed     Text format     Abstract available

  33. LI H, Torabi SJ, Park HS, Yarbrough WG, et al
    Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.
    Laryngoscope. 2019;129:1844-1855.
    PubMed     Text format     Abstract available


    Oral Oncol

  34. YAP T, Seers C, Koo K, Cheng L, et al
    Non-invasive screening of a microRNA-based dysregulation signature in oral cancer and oral potentially malignant disorders.
    Oral Oncol. 2019;96:113-120.
    PubMed     Text format     Abstract available

  35. LAURITANO D, Oberti L, Gabrione F, Lucchese A, et al
    Liquid biopsy in head and neck squamous cell carcinoma: Prognostic significance of circulating tumor cells and circulating tumor DNA. A systematic review.
    Oral Oncol. 2019;97:7-17.
    PubMed     Text format    

  36. FAKURNEJAD S, van Keulen S, Nishio N, Engelen M, et al
    Fluorescence molecular imaging for identification of high-grade dysplasia in patients with head and neck cancer.
    Oral Oncol. 2019;97:50-55.
    PubMed     Text format     Abstract available

  37. ZHU J, Duan B, Shi H, Li Y, et al
    Comparison of GP and TPF induction chemotherapy for locally advanced nasopharyngeal carcinoma.
    Oral Oncol. 2019;97:37-43.
    PubMed     Text format     Abstract available

  38. SUN XS, Lin C, Liang YJ, Chen QY, et al
    Role of zoledronic acid in nasopharyngeal carcinoma patients with bone-only metastasis at diagnosis.
    Oral Oncol. 2019;97:31-36.
    PubMed     Text format     Abstract available

  39. HAM JC, van Herpen CML, Driessen CML, van der Graaf WTA, et al
    Health-related quality of life of patients treated with chemoradiotherapy plus or minus prophylactic antibiotics to reduce the number of pneumonias for locally advanced head and neck cancer, the PANTAP study.
    Oral Oncol. 2019;96:105-112.
    PubMed     Text format     Abstract available

  40. YANG LL, Mao L, Wu H, Chen L, et al
    pDC depletion induced by CD317 blockade drives the antitumor immune response in head and neck squamous cell carcinoma.
    Oral Oncol. 2019;96:131-139.
    PubMed     Text format     Abstract available

  41. FADEN DL, Ding F, Lin Y, Zhai S, et al
    APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma.
    Oral Oncol. 2019;96:140-147.
    PubMed     Text format     Abstract available

  42. LIN C, Puram SV, Bulbul MG, Sethi RK, et al
    Elective neck dissection for salvage laryngectomy: A systematic review and meta-analysis.
    Oral Oncol. 2019;96:97-104.
    PubMed     Text format     Abstract available

  43. GIULIANI J, Bonetti A
    Immune-checkpoint inhibitors in head and neck squamous cell carcinoma: cost-efficacy in second-line treatment based on programmed death-ligand 1 (PD-L1) level.
    Oral Oncol. 2019 Aug 17. pii: S1368-8375(19)30286.
    PubMed     Text format    

  44. JAJODIA A, Aggarwal D, Chaturvedi AK, Rao A, et al
    Value of diffusion MR imaging in differentiation of recurrent head and neck malignancies from post treatment changes.
    Oral Oncol. 2019;96:89-96.
    PubMed     Text format     Abstract available

  45. SALOURA V, Izumchenko E, Zuo Z, Bao R, et al
    Immune profiles in primary squamous cell carcinoma of the head and neck.
    Oral Oncol. 2019;96:77-88.
    PubMed     Text format     Abstract available

  46. SABA NF, Blumenschein G Jr, Guigay J, Licitra L, et al
    Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age.
    Oral Oncol. 2019;96:7-14.
    PubMed     Text format     Abstract available

  47. MOON JH, Rho YS, Lee SH, Koo BS, et al
    Role of integrin beta1 as a biomarker of stemness in head and neck squamous cell carcinoma.
    Oral Oncol. 2019;96:34-41.
    PubMed     Text format     Abstract available

  48. CHUNG CS, Lo WC, Chen KC, Lin CL, et al
    Clinical benefits from endoscopy screening of esophageal second primary tumor for head and neck cancer patients: Analysis of a hospital-based registry.
    Oral Oncol. 2019;96:27-33.
    PubMed     Text format     Abstract available

  49. DEGRAAFF LH, Platek AJ, Iovoli AJ, Wooten KE, et al
    The effect of time between diagnosis and initiation of treatment on outcomes in patients with head and neck squamous cell carcinoma.
    Oral Oncol. 2019;96:148-152.
    PubMed     Text format     Abstract available


    Radiother Oncol

  50. RADES D, Narvaez CA, Splettstosser L, Domer C, et al
    A randomized trial (RAREST-01) comparing Mepitel(R) Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN).
    Radiother Oncol. 2019 Aug 17. pii: S0167-8140(19)33016.
    PubMed     Text format     Abstract available

  51. ZHAN M, Zheng H, Yang Y, Xu T, et al
    Cost-effectiveness analysis of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced esophageal squamous cell carcinoma based on the NEOCRTEC5010 trial.
    Radiother Oncol. 2019 Aug 17. pii: S0167-8140(19)33024.
    PubMed     Text format     Abstract available

  52. HEUKELOM J, Kantor ME, Mohamed ASR, Elhalawani H, et al
    Differences between planned and delivered dose for head and neck cancer, and their consequences for normal tissue complication probability and treatment adaptation.
    Radiother Oncol. 2019 Aug 17. pii: S0167-8140(19)33027.
    PubMed     Text format     Abstract available

  53. KUBO N, Kubota Y, Kawamura H, Oike T, et al
    Dosimetric parameters predictive of nasolacrimal duct obstruction after carbon-ion radiotherapy for head and neck carcinoma.
    Radiother Oncol. 2019 Aug 19. pii: S0167-8140(19)33015.
    PubMed     Text format     Abstract available

  54. VAN DEN BOSCH S, Doornaert PAH, Dijkema T, Zwijnenburg EM, et al
    (18)F-FDG-PET/CT-based treatment planning for definitive (chemo)radiotherapy in patients with head and neck squamous cell carcinoma improves regional control and survival.
    Radiother Oncol. 2019 Aug 19. pii: S0167-8140(19)33018.
    PubMed     Text format     Abstract available


    Thyroid

  55. YAISH I, Azem F, Tordjman KM
    Re: "Effects of Radioactive Iodine Therapy on Ovarian Reserve: A Prospective Pilot Study" by Evranos et al. (Thyroid 2018;28:1702-1707).
    Thyroid. 2019;29:453.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: